Apple's First Foldable iPhone: Genuine Leap Forward, Overpriced Catch-Up, or a Crease Waiting to Happen?
Apple is widely expected to unveil its first foldable iPhone — rumored as "iPhone Fold" or "iPhone Ultra" — at a September 2026 event alongside the iPhone 18 Pro lineup. Analysts including JPMorgan have pegged the price at roughly $1,999 to $2,300, with leaks pointing to a titanium-and-aluminum body, an A20 chip, the return of Touch ID, and a hinge engineered to minimize the visible crease. Coverage has repeatedly framed the device against Samsung's Galaxy Z Fold8 (reviewed July 29, 2026) and Samsung's CES 2026 creaseless-display demo, with outlets split on whether Apple's crease-reduction approach is a real engineering edge or a late response to years of Samsung foldable iteration. As of today, no official Apple announcement or hands-on review has happened yet — all coverage remains pre-launch leaks and analyst speculation.
Poll as Guest Infographics
Similar to hewsay's "Apple's First Foldable iPhone: Genuine Leap Forward, Overpriced Catch-Up, or a Crease Waiting to Happen?"
# Apple's 2026 Foldable iPhone Has No Display Crease – Report : r/iphone. Skip to main contentApple's 2026 Foldable iPhone Has No Display Crease – Report : r/iphone. Open menu Open navigationGo to Reddit Home. Get App Get the Reddit app Log InLog in to Reddit. Expand user menu...
Apple's 2026 Foldable iPhone Has No Display Crease – Report : r/apple Skip to main contentApple's 2026 Foldable iPhone Has No Display Crease – Report : r/apple Open menu Open navigationGo to Reddit Home r/apple A chip A close button Get App Get the Reddit app Log InLog in to R...
Moderna's cancer vaccine stock rocketed 177% then crashed 25% the next day — and RFK Jr had axed $500M in mRNA funding a year earlier. Who read this right?
On August 19, 2026, Merck and Moderna announced that their personalized mRNA cancer vaccine "intismeran," paired with Merck's Keytruda, showed a "clinically meaningful improvement" over Keytruda alone in a Phase 3 trial for high-risk melanoma patients after surgery — the first-ever randomized late-stage trial to test this approach. Moderna's stock exploded 177% that day, its best day ever, briefly valuing the company near $70 billion, while Merck shares also jumped. The catch: the companies didn't release the actual numbers, saying full data would come at a future medical conference. The next day, Moderna stock plunged 25%, wiping out about $18 billion in value, which analysts mostly blamed on profit-taking rather than doubt about the science (one Bank of America analyst still quadrupled his price target to $170). This all lands a year after HHS Secretary Robert F. Kennedy Jr. cancelled nearly $500 million across 22 mRNA vaccine development projects in August 2025, arguing mRNA "fails to protect effectively" against illnesses like COVID and flu — cuts that mostly hit respiratory-vaccine work, not this cancer program, but that fueled broader skepticism about the entire mRNA platform. Moderna's president said he hopes this week's results help move mRNA past being "pigeonholed" as just pandemic vaccine tech.
Poll as Guest Infographics
Similar to hewsay's "Moderna's cancer vaccine stock rocketed 177% then crashed 25% the next day — and RFK Jr had axed $500M in mRNA funding a year earlier. Who read this right?"
MRNA bounce incoming : r/wallstreetbets. Open menu Open navigationGo to Reddit Home. Sell the loss and use the cash for the play? Continue this thread1 more reply. Continue this thread21 more replies. OP only needs to convince enough of us to make his money back. Author is con...
How RFK Jr.’s misguided science on mRNA vaccines is shaping policy − a vaccine expert examines the false claims : r/politics. Skip to main contentHow RFK Jr.’s misguided science on mRNA vaccines is shaping policy − a vaccine expert examines the false claims : r/politics. Open ...